Glenmark Pharmaceuticals Legal & Regulatory

Glenmark Pharmaceuticals Earnings Call Transcript: Key Takeaways

Like-for-like growth ~20% and ex-IGI EBITDA margin 21%, yet H1 operating cash was negative; H2 cash recovery is the test.

Glenmark Pharmaceuticals Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue Rs 42,473 Mn, down 29.8% YoY on a reported basis. EBITDA Rs 8,638 Mn (20.3% margin); Adj PAT Rs 4,852 Mn (11.4% margin). North America headline is flattered by ISB 2001 licensing income.

Glenmark Pharmaceuticals Results Update

Glenmark Pharmaceuticals released its Q2 FY27 press release and MD&A for the quarter ended September 2026. Highlights show India growth and lower North America revenue.

Glenmark Pharmaceuticals Q2 FY27 Results: Net Profit ₹263.8 Cr, Down 56.8% YoY

Glenmark Pharmaceuticals Ltd reported revenue from operations of ₹4,247 Cr (-29.8% YoY) and net profit of ₹263.8 Cr (-56.8% YoY) for Q2 FY27.

Key figure

Net profit ₹263.8 Cr · -56.8% YoY

Glenmark Pharmaceuticals Other Announcement

Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.

Glenmark Pharmaceuticals Board Meeting Date

Glenmark Pharmaceuticals notified BSE of a board meeting on 05 Nov 2026 to consider unaudited Q2 FY27 results. No financial figures are disclosed in this advance intimation.

Tata Power Company Legal & Regulatory

Tata Power discloses Singapore court developments in its Kleros arbitration, including share attachment notices to two subsidiaries. Detailed appeal submissions are due November 23, 2026.

Baroda Rayon Corporation Legal & Regulatory

Baroda Rayon's ITAT Mumbai allowed both its quantum and penalty appeals for AY 2014-15, deleting a ₹12.15 Crore Section 68 addition and a ₹4.13 Crore penalty. The filing updates a pending tax litigation disclosed earlier.

Value

₹12.15 Cr

HD Fire Protect Legal & Regulatory

HD Fire Protect received a GST order dropping a ₹7.10 Crore show-cause demand for FY 2022-23. The order has no financial or operational impact on the company.

Value

₹7.10 Cr

EKI Energy Services Legal & Regulatory

EKI Energy's counterparty Vitol terminated an emission reduction agreement and invoked a USD 10 million bank guarantee. The company disputes the default claim and plans arbitration.

Value

₹94.00 Cr

Mangalore Refinery And Petrochemicals Legal & Regulatory

MRPL received a Customs order demanding ₹1,39,871 plus interest and penalty for 2021 tariff misclassification. The company is considering challenging the order after depositing the money.

Value

₹0.01 Cr

Alfa Ica (India) Legal & Regulatory

Alfa Ica India's board noted a ₹9,440 BSE fine for late Annual Report filing under Regulation 34. The penalty was remitted and stronger compliance tracking was advised.

Value

₹0.00 Cr